MRNA vs PAR · rev $145.0M vs rev $257.4M
Moderna Inc (MRNA) versus PAR Technology Corporation (PAR) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
PAR Technology Corporation (PAR) is a software - application company listed on NYSE.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported PAR revenue for 2026-06-30 was $257.4M. Net income was -$33.1M. PAR currently screens at market cap $612.5M.
MRNA currently screens at market cap $24.52B. PAR currently screens at market cap $612.5M.
Not investment advice. Open the MRNA and PAR stock pages for the full models.
Not investment advice.